NP Life Sciences Health Industry Group Inc. Cash and Cash Equivalents
NP Life Sciences Health Industry Group Inc. (ACAT) had Cash and Cash Equivalents of $70.61 thousand as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-04-16
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $70.61K.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $84.55K.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $125.11K.
- 2023-03-31: Cash and Cash Equivalents, at Carrying Value $140.08K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2023-12-31 | $70.61K 10-K · filed 2024-04-16 |
| 2023-09-30 | $84.55K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $125.11K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $140.08K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $121.86K 10-K · filed 2024-04-16 |
| 2022-09-30 | $6.95K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $575.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $23.12K 10-Q · filed 2022-05-23 |
| 2021-12-31 | $27.99K 10-K · filed 2023-04-18 |
| 2021-09-30 | $25.01K 10-Q · filed 2021-11-22 |
| 2021-06-30 | $40.73K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $89.43K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $118.61K 10-K · filed 2022-04-15 |
| 2020-09-30 | $144.99K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $168.52K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $222.22K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $242.93K 10-K · filed 2021-04-15 |
| 2019-09-30 | $276.62K 10-Q · filed 2019-11-15 |
| 2018-12-31 | $200.00 10-K · filed 2020-03-30 |